Cited by 78

The DOI matches its Crossref record.

The Chaperone Activity of GRP94 Toward Insulin-like Growth Factor II Is Necessary for the Stress Response to Serum Deprivation

Ostrovsky, Olga, Ahmed, Noreen T., Argon, Yair·2009·Molecular Biology of the Cell

Abstract

Insulin-like growth factor (IGF)-II is a hormone with mitogenic activity for many cell types and tissues. We demonstrate that its intracellular processing and secretion strictly depend on the endoplasmic reticulum chaperone glucose-regulated protein (GRP) 94. GRP94 interacts physically and transiently with pro-IGF-II intermediates, and its activity is essential for secretion of active IGF-II, thus establishing IGF-II as a client of GRP94. Embryonic stem (ES) cells that lack GRP94 are hypersensitive to stress conditions such as serum deprivation and die by apoptosis because they cannot respond to the stress by producing active IGF-II. This chaperone–client interaction may explain the previously documented antiapoptotic activity of GRP94 in a number of stress responses.

Overview

Integrity signals

Registry

Crossref · 10.1091/mbc.e08-04-0346

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Argon Y., 1999, Semin. Cell Dev. Biol, 10, 495, 10.1006/scdb.1999.0320 · DOI
  2. Arias A. E., 2000, J. Cell Sci, 113, 2075, 10.1242/jcs.113.11.2075 · DOI
  3. Baker J., 1993, Cell, 75, 73, 10.1016/S0092-8674(05)80085-6 · DOI · Paper page
  4. Bando Y., 2004, Apoptosis, 9, 501, 10.1023/B:APPT.0000031446.95532.ad · DOI
  5. Bando Y., 2003, Eur. J. Neurosci, 18, 829, 10.1046/j.1460-9568.2003.02818.x · DOI
  6. Biswas C., 2007, Biochem. J, 405, 233, 10.1042/BJ20061867 · DOI
  7. Christianson J. C., 2008, Nat. Cell Biol, 10, 272, 10.1038/ncb1689 · DOI · Paper page
  8. Crouch G. D., 1991, Cancer Res, 51, 4882
  9. De Giovanni C., 1995, Br. J. Cancer, 72, 1224, 10.1038/bjc.1995.490 · DOI
  10. Drummond I. A., 1987, J. Biol. Chem, 262, 12801, 10.1016/S0021-9258(18)45277-5 · DOI
  11. Duguay S. J., 1998, J. Biol. Chem, 273, 18443, 10.1074/jbc.273.29.18443 · DOI
  12. Engstrom W., 1998, Cell Prolif, 31, 173, 10.1111/j.1365-2184.1998.tb01196.x · DOI
  13. Gilchrist A., 2006, Cell, 127, 1265, 10.1016/j.cell.2006.10.036 · DOI
  14. Grimberg A., 2000, J. Cell Physiol, 183, 1, 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J · DOI
  15. Hober S., 1999, FEBS Lett, 443, 271, 10.1016/S0014-5793(98)01737-2 · DOI
  16. Ishiguro S., 2002, EMBO J, 21, 898, 10.1093/emboj/21.5.898 · DOI
  17. Kim Y. K., 1987, J. Cell Physiol, 133, 553, 10.1002/jcp.1041330317 · DOI
  18. Koch G., 1986, J. Cell Sci, 86, 217, 10.1242/jcs.86.1.217 · DOI
  19. Lee A. S., 1983, J. Biol. Chem, 258, 597, 10.1016/S0021-9258(18)33296-4 · DOI
  20. Lee J. E., 1990, Development, 110, 151, 10.1242/dev.110.1.151 · DOI
  21. LeRoith D., 2003, Cancer Lett, 195, 127, 10.1016/S0304-3835(03)00159-9 · DOI
  22. Little E., 1994, Crit. Rev. Eukaryot. Gene Expr, 4, 1, 10.1615/CritRevEukarGeneExpr.v4.i1.10 · DOI
  23. Liu H., 1997, J. Biol. Chem, 272, 21751, 10.1074/jbc.272.35.21751 · DOI
  24. Loo M. A., 1998, EMBO J, 17, 6879, 10.1093/emboj/17.23.6879 · DOI
  25. McCormick T. S., 1997, J. Biol. Chem, 272, 6087, 10.1074/jbc.272.9.6087 · DOI
  26. Melnick J., 1994, Nature, 370, 373, 10.1038/370373a0 · DOI
  27. Paris S., 2005, FEBS Lett, 579, 105, 10.1016/j.febslet.2004.11.055 · DOI
  28. Prelle K., 2000, Biochem. Biophys. Res. Commun, 277, 631, 10.1006/bbrc.2000.3737 · DOI
  29. Randow F., 2001, Nat. Cell Biol, 3, 891, 10.1038/ncb1001-891 · DOI · Paper page
  30. Reddy R. K., 1999, J. Biol. Chem, 274, 28476, 10.1074/jbc.274.40.28476 · DOI
  31. Rosen K. M., 1993, Endocrinology, 133, 474, 10.1210/endo.133.2.8393762 · DOI
  32. Schmitz A., 1995, EMBO J, 14, 1091, 10.1002/j.1460-2075.1995.tb07092.x · DOI
  33. Schulte T. W., 1998, Cancer Chemother. Pharmacol, 42, 273, 10.1007/s002800050817 · DOI
  34. Smith J., 2000, Cell Death Differ, 7, 1109, 10.1038/sj.cdd.4400738 · DOI
  35. Sugawara S., 1993, Cancer Res, 53, 6001
  36. Sullivan K. A., 1997, Brain Res, 744, 199, 10.1016/S0006-8993(96)01078-5 · DOI
  37. van Doorn J., 2002, Clin. Chem, 48, 1739, 10.1093/clinchem/48.10.1739 · DOI
  38. Vogen S. M., 2002, J. Biol. Chem, 277, 40742, 10.1074/jbc.M205323200 · DOI
  39. 10.1091/mbc.e07-03-0275 · DOI
  40. Yang Y., 2007, Immunity, 26, 215, 10.1016/j.immuni.2006.12.005 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Ostrovsky, O., Ahmed, N. T., & Argon, Y.
Affiliations
Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, PA 19104
Venue
Molecular Biology of the Cell
Published
2009-03-15
Volume
20
Issue
6
Pages
1855-1864
ISSN
  • 1059-1524
  • 1939-4586
Cited by
78
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review